
Levocetirizine (5mg) + Montelukast (10mg)
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Mintopar-L Tablet is a fixed-dose combination medication containing Levocetirizine 5mg and Montelukast 10mg. It is indicated for the treatment of symptoms associated with allergic rhinitis, including sneezing, runny nose, itchy and watery eyes, and nasal congestion. Levocetirizine, an antihistamine, helps to relieve pruritus, hives, and skin itching, while Montelukast, a leukotriene receptor antagonist, inhibits the production of leukotrienes, which contribute to bronchospasm and increased mucus production. By combining these two agents, Mintopar-L Tablet offers a comprehensive treatment approach for patients experiencing symptoms of allergic rhinitis. The medication is available in a once-daily tablet formulation, allowing for convenient dosing. In clinical trials, Mintopar-L Tablet has been shown to be effective in reducing symptoms of allergic rhinitis, including nasal congestion, sneezing, and itchy and watery eyes, and has a well-tolerated safety profile.
How to use Mintopar-L Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mintopar-L Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Mintopar-L Tablet. Please consult your doctor.
High Risk
Mintopar-L Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Mintopar-L Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Mintopar-L Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Mintopar-L Tablet may be needed. Please consult your doctor. Limited information is available on the use of Mintopar-L Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Mintopar-L Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Mintopar-L Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mintopar-L Tablet may be needed. Please consult your doctor. Use of Mintopar-L Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Mintopar-L Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Mintopar-L Tablet is a fixed-dose combination medication containing Levocetirizine 5mg and Montelukast 10mg. It is indicated for the treatment of symptoms associated with allergic rhinitis, including sneezing, runny nose, itchy and watery eyes, and nasal congestion. Levocetirizine, an antihistamine, helps to relieve pruritus, hives, and skin itching, while Montelukast, a leukotriene receptor antagonist, inhibits the production of leukotrienes, which contribute to bronchospasm and increased mucus production. By combining these two agents, Mintopar-L Tablet offers a comprehensive treatment approach for patients experiencing symptoms of allergic rhinitis. The medication is available in a once-daily tablet formulation, allowing for convenient dosing. In clinical trials, Mintopar-L Tablet has been shown to be effective in reducing symptoms of allergic rhinitis, including nasal congestion, sneezing, and itchy and watery eyes, and has a well-tolerated safety profile.
How to use Mintopar-L Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mintopar-L Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Mintopar-L Tablet. Please consult your doctor.
High Risk
Mintopar-L Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Mintopar-L Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Mintopar-L Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Mintopar-L Tablet may be needed. Please consult your doctor. Limited information is available on the use of Mintopar-L Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Mintopar-L Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Mintopar-L Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mintopar-L Tablet may be needed. Please consult your doctor. Use of Mintopar-L Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Mintopar-L Tablet















